Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 658 is a small, single-stranded, non-coding RNA molecule that is evolutionarily conserved and functions primarily through base-pairing with complementary sequences in target messenger RNAs (mRNAs)[1]. It acts by destabilizing target mRNA, cleaving mRNA, or reducing mRNA translation into proteins[1][5]. The miRNA 658 gene is located in the human genome, but its biological role and disease associations are not well-characterized in current scientific literature. MicroRNAs, including MIR658, are critical components of the gene regulatory network and may influence biological processes such as development, differentiation, apoptosis, and disease pathogenesis by regulating the expression of multiple target genes[4][6]. However, there is no specific evidence that MIR658 itself is a therapeutic target, receptor, or biomarker at present. If you need structured information for database purposes, MIR658 should be classified under microRNA/non-coding RNA, not a classical drug target, and no disease or drug associations currently documented.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 658 (MIR658).